Long-Term Safety and Efficacy of Lubiprostone in Opioid-induced Constipation in Patients with Chronic Noncancer Pain.

Spierings, Egilius L H; Rauck, Richard; Brewer, Randall; Marcuard, Stefano; Vallejo, Ricardo

Spierings, Egilius L H; Rauck, Richard; Brewer, Randall; Marcuard, Stefano; Vallejo, Ricardo.

Afiliação

Spierings ELH; Headache & Face Pain Program, Tufts Medical Center, and Craniofacial Pain Center, Tufts University School of Dental Medicine, Boston, Massachusetts, U.S.A.
Rauck R; The Carolinas Pain Institute, Winston-Salem, North Carolina, U.S.A.
Brewer R; Duke University Medical Center, Durham, North Carolina, U.S.A.
Marcuard S; Carolina Digestive Diseases, Greenville, North Carolina, U.S.A.
Vallejo R; Millennium Pain Center, Bloomington, Illinois, U.S.A.

Pain Pract ; 16(8): 985-993, 2016 Nov.

Article em En | MEDLINE | ID: mdl-26328775

Palavras-chave

ClC-2; bowel dysfunction; bowel movement; chloride channel activator; constipation; lubiprostone; opioid-induced constipation; pain management

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2016 Tipo de documento: Article